Spots Global Cancer Trial Database for recurrent kaposi sarcoma
Every month we try and update this database with for recurrent kaposi sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma | NCT00006222 | Sarcoma | cilengitide | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00003720 | Sarcoma | semaxanib | 18 Years - | Pfizer | |
| Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma | NCT00096538 | Sarcoma | valganciclovir | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | NCT00003207 | Sarcoma Unspecified Adu... | pegylated lipos... PSC 833 | 18 Years - | Washington University School of Medicine | |
| Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma | NCT00450320 | Sarcoma | sirolimus | 18 Years - | AIDS Malignancy Consortium | |
| Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma | NCT01016730 | AIDS-Related Ka... HIV Infection Recurrent Kapos... | Bortezomib Laboratory Biom... Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma | NCT00096538 | Sarcoma | valganciclovir | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV | NCT04514484 | Advanced Differ... Advanced Head a... Advanced Hepato... Advanced Kaposi... Advanced Lung N... Advanced Lung S... Advanced Malign... Advanced Melano... Advanced Ovaria... Advanced Prosta... Advanced Renal ... Advanced Thyroi... Advanced Triple... Advanced Urothe... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HIV Infection Metastatic Diff... Metastatic Head... Metastatic Hepa... Metastatic Kapo... Metastatic Lung... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Ovar... Metastatic Pros... Metastatic Rena... Metastatic Thyr... Metastatic Trip... Metastatic Urot... Recurrent Diffe... Recurrent Head ... Recurrent Hepat... Recurrent Kapos... Recurrent Lung ... Recurrent Lung ... Recurrent Malig... Recurrent Melan... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Thyro... Recurrent Tripl... Recurrent Uroth... Refractory Diff... Stage III Diffe... Stage III Hepat... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Thyro... Stage IV Differ... Stage IV Hepato... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Thyroi... | Biospecimen Col... Cabozantinib S-... Computed Tomogr... Magnetic Resona... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00005042 | Sarcoma | semaxanib | 18 Years - | AIDS Malignancy Consortium | |
| Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma | NCT00096538 | Sarcoma | valganciclovir | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00020449 | Sarcoma | recombinant int... paclitaxel pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma | NCT02137564 | AIDS-related Ka... HIV Infection Recurrent Kapos... | gamma secretase... pharmacological... laboratory biom... | 18 Years - | AIDS Malignancy Consortium | |
| Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00003008 | Sarcoma | indinavir sulfa... nelfinavir mesy... paclitaxel ritonavir saquinavir mesy... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection | NCT00019240 | Sarcoma | cidofovir | 18 Years - | National Cancer Institute (NCI) | |
| Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma | NCT00295984 | Sarcoma | nicotine | 18 Years - 78 Years | National Cancer Institute (NCI) | |
| Liposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma | NCT00020449 | Sarcoma | recombinant int... paclitaxel pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
| Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection | NCT00019240 | Sarcoma | cidofovir | 18 Years - | National Cancer Institute (NCI) | |
| EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma | NCT00006222 | Sarcoma | cilengitide | 18 Years - | National Cancer Institute (NCI) | |
| EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma | NCT00006222 | Sarcoma | cilengitide | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma | NCT01016730 | AIDS-Related Ka... HIV Infection Recurrent Kapos... | Bortezomib Laboratory Biom... Questionnaire A... | 18 Years - | National Cancer Institute (NCI) | |
| Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma | NCT00295984 | Sarcoma | nicotine | 18 Years - 78 Years | National Cancer Institute (NCI) | |
| Valproic Acid in Treating Patients With Kaposi's Sarcoma | NCT00075777 | Sarcoma | valproic acid | 18 Years - | AIDS Malignancy Consortium | |
| PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma | NCT00686842 | Kaposi's Sarcom... | VEGF inhibitor ... gene expression... polymerase chai... protein express... immunohistochem... laboratory biom... pharmacological... biopsy | 18 Years - 120 Years | AIDS Malignancy Consortium | |
| Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection | NCT00019240 | Sarcoma | cidofovir | 18 Years - | National Cancer Institute (NCI) | |
| Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma | NCT03077451 | Recurrent Kapos... Skin Kaposi Sar... | Laboratory Biom... Nelfinavir Mesy... | 18 Years - | AIDS Malignancy Consortium |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
